Brief: IGM Biosciences Q2 Net Income USD -47.902 Million
14/08/2024 12:00
Aug 14 (Reuters) - IGM Biosciences Q2 operating income USD -51.357 million. * Q2 operating expenses USD 52.611 million * Q2 basic EPS USD -0.79 * Q2 collaboration revenue USD 1.254 million * Q2 pretax profit USD -47.902 million
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary